Because acute procedural pain tends to increase with procedure time, assessments of pain management strategies must take that time relationship into account. Statistical time-course analyses are, however, complex and require large patient numbers to detect differences. The current study evaluated the abilities of various single and simple composite measures such as averaged pain or individual patient pain slopes to detect treatment effects. Secondary analyses were performed with the data from 3 prospective randomized clinical trials that assessed the effect of a self-hypnotic relaxation intervention on procedural pain, measured every 10-15 minutes during vascular/renal interventions, breast biopsies, and tumor embolizations. Single point-in-time and maximal pain comparisons were poor in detecting treatment effects. Linear data sets of individual patient slopes yielded the same qualitative results as the more complex repeated measures analyses, allowing the use of standard statistical approaches (eg, Kruskal-Wallis), and promising analyses of smaller subgroups, which otherwise would be underpowered. With nonlinear data, a simple averaged score was highly sensitive in detecting differences. Use of these 2 workable and relatively simple approaches may be a first step towards facilitating the development of data sets that could enable meta-analyses of data from acute pain trials. Ó
Introduction
Contemporary health care strives to be evidence-based. While one properly designed prospective randomized trial may suffice to establish some confidence in the relative risks and benefits of a specific treatment, the highest level of evidence derives from concurrent results of several such trials [3] . The premise of this view is that the measures used in different trials are comparable and can easily be combined and entered in meta-analyses. With objective single-point outcome measures such as disease-free intervals or survival time, the task is relatively straightforward. However, when outcome measures are multidimensional, subjective, and have uncertain trajectories and time intervals across subjects-such as is the case for measures used in pain clinical trials-assessment methods become more complex [7] .
The National Institute of Health initiated the Toolbox project to provide a set of brief, validated outcome measures that can be used across diverse study designs. To assess pain, the Toolbox includes a 0-10 numeric intensity rating scale and a pain interference item bank [5] . Investigators still need to decide whether to choose single, multiple, averaged, or otherwise aggregated measures to reflect treatment effects [8] .
Common approaches are point-in-time comparisons, the use of averages [1, 9, 18, 19] , and maximal pain measures [14, 15, 17] . Jensen and colleagues showed that in the assessment of chronic pain a single 24-hour recall rating can potentially be as valid (sensitive) for detecting treatment differences as 9 individual measures combined, allowing considerable savings in cost and burden of clinical trials [7] (but see also Stone et al. [16] ). Assessing the effect of interventions on stimulus-evoked or procedural acute pain may not, however, be as straightforward, because the time factor is a more critical element of analysis.
In a clinical trial of patients undergoing invasive vascular and renal procedures, patients' pain perception increased linearly over time under standard care conditions [10] . This phenomenon was replicated in 2 subsequent studies [11, 12] , indicating a need for time-sensitive methods of analysis. However, time-series analyses require large sample sizes and complex statistical approaches. Moreover, with effective interventions, the appearance of zeroscore pain assessments can make transformation into normally 
